abstract |
The present invention provides virosome preparations from enveloped viruses (especially influenza viruses) containing virus-derived antigens and saponin adjuvants. Specifically, the present invention provides a virosome preparation from influenza virus containing an influenza antigen and QS21, optionally with sterols. The present invention also provides vaccine formulations comprising virosome preparations, methods for producing virosome preparations, and vaccines comprising them. [Selection] Figure 4 |